Focus on the individual - Quality of life assessments in oncology

Acta Oncologica

Volumn 41, Issue 6, 2002, Pages 507-516

  Kettis Lindblad, Åsa ^a,b   Ring, Lena ^a,b   Glimelius, Bengt ^a   Hansson, Mats G ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL EQUIPMENT; HEALTH CARE; PATIENT TREATMENT;

QUALITY OF LIFE;

ONCOLOGY;

ACCURACY; ANALYTIC METHOD; AUTOMATION; CLINICAL PRACTICE; FOLLOW UP; INDIVIDUALIZATION; INSTRUMENTATION; MEDICAL DECISION MAKING; ONCOLOGY; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; REVIEW; SCORING SYSTEM;

EID: 0036923773     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860214962     Document Type: Review

References (94)

1. Nordenfelt L. Quality of life: The concept and its application in health care. Introduction. Ethic Theory Moral Pract 1999; 2: 3-10.
2. Macduff C. Respondent-generated quality of life measures: Useful tools for nursing or more fool's gold? J Adv Nuts 2000; 32: 375-82.
3. Gunnars B, Nygren P, Glimelius B. Assessment of quality of life during chemotherapy. Acta Oncol 2001; 40: 175-84.
4. Aaronson NK. Methodologic issues in assessing the quality of life of cancer patients. Cancer 1991; 67 (Suppl 3): 844-50.
5. Joyce CRB, McGee HM, O'Boyle CA, eds. Individual Quality of Life: Approaches to Conceptualisation and Assessment. Singapore: Harwood Academic Publishers, 1999.
6. Ganz PA. Impact of quality of life outcomes on clinical practice. Oncology (Huntingt) 1995; 9 (Suppl 11): 61-5.
7. Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH. How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol 2000; 18: 3295-301.
8. Taenzer P, Bultz BD, Carlson LE, et al. Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psychooncology 2000; 9: 203-13.
9. Detmar SB, Aaronson NK. Quality of life assessment in daily clinical oncology practice: A feasibility study. Eur J Cancer 1998; 34: 1181-6.
10. Annells M, Koch T, Brown M. Client relevant care and quality of life: The trial of a client generated index (CGI) tool for community nursing. Int J Nuts Stud 2001; 38: 9-16.
11. Detmar SB, Muller M J, Schornagel JH, Wever LDV, Aaronson NK. Role of health-related quality of life in palliative chemotherapy treatment decisions. J Clin Oncol 2002; 20: 1056-62.
12. Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual Life Res 1998; 7: 85-91.
13. Higginson I. A community schedule. In: Higginson I, ed. Clinical Audit in Palliative Care. Oxford: Radcliffe Medical Press, 1993: 34-7.
14. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 1991; 7: 6-9.
15. Cleeland CS. Measurement of pain by subjective report. In: Chapman CR, Loeser JD, eds. Advances in Pain Research and Management, vol 12. Issues in Pain Management. New York: Raven Press, 1989: 391-403.
16. Fishman B, Pasternak S, Wallenstein SL, Houde RW, Holland JC, Foley KM. The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer 1987; 60: 1151-8.
17. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30A: 1326-36.
18. Michael M, Tannock IF. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ 1998; 158: 1727-34.
19. Sprangers M. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 2002; 41: 229-37.
20. McHorney CA, Tarlow AR. Individual patient monitoring in clinical practice: Are available health status surveys adequate? Qual Life Res 1995; 4: 293-307.
21. Gill T, Feinsten AR. A critical appraisal of the quality of life measurements. JAMA 1994; 272: 619-26.
22. Farquhar M. Definitions of quality of life: A taxonomy. J Adv Nuts 1995; 22: 502-8.
23. World Health Organisation. Official Record of the World Health Organisation. Geneva: WHO; 1948: Report No 2.
24. Browne J, McGee H, O'Boyle C. Conceptual approaches to the assessment of quality of life. Psychol Health 1997; 12: 737-51.
25. Rustoen T, Moum T, Wiklund. I, Hanestad BR. Quality of life in newly diagnosed cancer patients. J Adv Nurs 1999; 29: 490- 8.
26. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: A theoretical model. Soc Sci Med 1999; 48: 1507-15.
27. Teno JM. Putting patient and family voice back in to measuring quality of care for the dying. Hospice J 1999; 14: 167-76.
28. Waldron D, O'Boyle CA, Kearney M, Moriarty M, Carney D. Quality-of-life measurement in advanced cancer: Assessing the individual. J Clin Oncol 1999; 17: 3603-11.
29. Donovan K, Sanson-Fisher RW, Redman S. Measuring quality of life in cancer patients. J Clin Oncol 1989; 7: 959-68.
30. Cohen SR, Mount BM, Tomas JJ, Mount LF. Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire. Cancer 1996; 77: 576-86.
31. Power M, Harper A, Bullinger M. The World Health Organization WHO QOL-100: Tests of the universality of quality of life in 15 different cultural groups worldwide. Health Psychol 1999; 18: 495-505.
32. Nussbaum M, Sen A, eds. The Quality of Life. New York: Oxford University Press Inc, 1993.
33. Kurtén T. Tillit, Verklighet och Värde (Trust, Reality and Value). Nora: Bokförlaget Nya Doxa, 1995. (In Swedish).
34. Pellegrino E, Mazzarella P, Corsi P, eds. Transcultural Dimensions in Medical Ethics. Frederick, MD: University Publishing Group, Inc, 1992.
35. Harris J. The Value of Life. An Introduction to Medical Ethics. New York: Routledge & Kegan Paul, 1985.
36. Ricoeur P. Judging life. In: Kemp P, Rendtorff J, Johansen NM, eds. Bioethics and Biolaw. Vol. I. Judgement of Life. Copenhagen: Rhodos International Science and Art Publishers & Centre for Ethics and Law; 2000.
37. Bråkenhielm CR, Hansson MG. Livets Grundmönster och Mångfald. En Bok om Genetik, Etik och Livsåskådning (The Fundamental Pattern and Diversity of Life. A Study of Genetics, Ethics and Life-views). Stockholm: Liber Utbildning, 1995. (In Swedish).
38. Jeffner A. Livsåskfådningar i Sverige. Inledande Projektpresentation och Översiktlig Resultatredovisning (Life-views in Sweden. An Introductory Presentation of the Project and an Overview of Results). Uppsala: Studies in Faith and Ideologies, 1988. (In Swedish).
39. Griffin J. Well-being. Its Meaning, Measurement and Moral Importance. Oxford: Clarendon Press, 1986.
40. Brady MJ, Peterman AH, Fitchett G, Mo M, Celia D. A case for including spirituality in quality of life measurement in oncology. Psycho-Oncol 1999; 8: 417-28.
41. Muldoon MKN. Spirituality, health care and bioethics. J Relig Health 1995; 34: 329-49.
42. McSherry W, Ross L. Dilemmas of spiritual assessment: Considerations for nursing practice. J Adv Nuts 2002; 38: 479-88.
43. Tully MP, Cantrill JA. Subjective outcome measurement - A primer. Pharm World Sci 1999; 21: 101-9.
44. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
45. Lomas J, Pickard L, Mohide A. Patient versus clinician item generation for quality-of-life measures. The case of language-disabled adults. Med Care 1987; 25: 764-9.
46. Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50: 441-50.
47. Cohen C. On the quality of life: Some philosophical reflections. Circulation 1982; 66 (Suppl III): 29-33.
48. Calman KC. Quality of life in cancer patients: A hypothesis. J Med Ethics 1984; 10: 124-7.
49. Damiano AM. The sickness impact profile. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers, 1996: 347-54.
50. Cella DF, Bonomi AE. The functional assessment of cancer therapy (FACT) and functional assessment of HIV infection (FAHI) quality of life measurement system. In: Spilker B, ed. Quality if Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers, 1996: 203-14.
51. Fayers P, Bottomley A, the EORTC Quality of Life Group and the Quality of Life Unit. Quality of life research within the EORTC - The EORTC QLQ-C30. Eur J Cancer 2002; 38: S125-S33.
52. Campbell S, Whyte F. The quality of life of cancer patients participating in phase I clinical trials using SEIQoL-DW. J Adv Nurs 1999; 30: 335-43.
53. O'Boyle CA, McGee H, Hickey A, O'Malley K, Joyce CR. Individual quality of life in patients undergoing hip replacement. Lancet 1992; 339: 1088-91.
54. McGee HM, O'Boyle CA, Hickey A, O'Malley K, Joyce CR. Assessing the quality of life of the individual: The SEIQoL with a healthy and a gastroenterology unit population. Psychol Med 1991; 21: 749-59.
55. Bowling A. What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life. Soc Sci Med 1995; 10: 1447-62.
56. Wright JG. Evaluating the outcome of treatment. Shouldn't we be asking patients if they are better? J Clin Epidemiol 2000; 53: 549-53.
57. Wood-Dauphinee S. Assessing quality of life in clinical research: From where have we come and where are we going? J Clin Epidemiol 1999; 52: 355-63.
58. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS. Br Med J 1996; 313: 29-33.
59. Hickey A, O'Boyle CA, McGee HM, Joyce CRB. The Schedule for the Evaluation of Individual Quality of Life. In: Joyce CRB, McGee HM, O'Boyle CA, eds. Individual Quality of Life. Approaches to Conceptualisation and Assessment. Singapore: Harwood Academic Publishers, 1999.
60. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care 1994; 32: 1109-26.
61. Macduff C, Russell E. The problem of measuring change in individual health-related quality of life by postal questionnaire: Use of the Patient-Generated Index in a disabled population. Qual Life Res 1998; 7: 761-9.
62. Ruta DA, Garratt AM, Russell IT. Patient-centred assessment of quality of life for patients with four common conditions. Qual Health Care 1999; 8: 22-9.
63. Jenkinson C, Stradling J, Petersen S. How should we evaluate health status? A comparison of three methods in patients presenting with obstructive sleep apnoea. Qual Life Res 1998; 7: 95-100.
64. Herd RM, Tidman MJ, Ruta DA, Hunter JA. Measurement of quality of life in atopic dermatitis: Correlation and validation of two different methods. Br J Dermatol 1997; 136: 502-7.
65. Ferrans CE. Development of a quality of life index for patients with cancer. Oncology Nurs Forum 1990; 17 (Suppl 3): 15-9.
66. Crom DB, Chataway DK, Tolley EA, Muhlern RK, Hudson MM. Health status and health-related quality of life in long-term adult survivors of pediatric solid tumors. Int J Cancer 1999; 12: 25-31.
67. Johnson DJ, Casey L, Noriega B. A pilot study of patient quality of life during radiation therapy treatment. Qual Life Res 1994; 3: 267-72.
68. Wright JG, Young NL. The Patient-Specific Index: Asking patients what they want. J Bone Joint Surg 1997; 79A: 974-83.
69. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B. The MACTAR Patient Preference Disability Questionnaire: An individualized functional priority approach for assessing improvement in physical disability in clinical trial in rheumatoid arthritis. J Rheumatol 1987; 14: 446-51.
70. Juniper EF, Guatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: Development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83.
71. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-8.
72. Juniper EF, Guyatt G. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21: 77-83.
73. Montazeri A, Gillis CR, McEwen J. Quality of life in patients with lung cancer: A review of literature from to 1995. Chest; 113 1970; 1998: 467-81.
74. Doward LC, McKenna P. Evolution of quality-of-life assessment. In: Rajagopalan R, Sherertz EF, Anderson RT, eds. Care Management of Skin Diseases, Life Quality and Economic Impact. New York: Marcel Dekker Inc, 1998: 9-33.
75. DeVellis RF. Scale Development. Theory and Applications. Newbury Park, CA: Sage Publications Inc, 1991: 86.
76. Fitzpatrick R. Assessment of quality of life as an outcome: Finding measurements that reflect individuals' priorities. Qual Health Care 1999; 8: 1-2.
77. Nordin K, Steel J, Hoffman K, Glimelius B. Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients. Br J Cancer 2001; 85: 1265-72.
78. McHorney CA. Generic health measurement: Past accomplishments and a measure paradigm for the 21st century. Ann Int Med 1997; 127: 743-50.
79. Jaeschke R, Singer JHGG. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15.
80. Lydick EG, Epstein RS. Clinical significance of quality of life data. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers, 1996.
81. Moser MT, Weis J, Fachinger D, Bartsch HH. Interpretation of quality of life-changes in inpatient rehabilitation programs for cancer patients. In: Seventh Annual Conference of the International Society for Quality of Life Research, 2000; Vancouver, Canada, 2000.
82. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27 (Suppl 2): S178-89.
83. Fayers PM, Machin D. Quality of Life. Assessment, Analysis and Interpretation. West Sussex: John Wiley & Sons, 2000.
84. Sloan J, Symmonds T. Health related quality of life measurement in clinical trials: When does a statistically significant change become clinically relevant? In: Workshop I, ed. Vancouver, 2000.
85. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15: 141-55.
86. Cleary PD. Future directions of quality of life. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippencott-Raven, 1996: 73-8.
87. Guess HA, Jacobsen SJ, Girman CJ, et al. The role of community-based longitudinal studies in evaluating treatment effects - Example: Benign prostatic hyperplasia. Med Care 1995; 33: AS26-35.
88. Jenkinson C, Ziebland S. Interpretation of data from health status measures: What do the numbers mean? In: Joyce CRB, McGee HM, O'Boyle CA, eds. Individual Quality of Life: Approaches to Conceptualisation and Assessment. Amsterdam: Harwood Academic Publishers, 1999: 75-86.
89. Glimelius B. Quality of life and methodology in colorectal cancer studies. In: Bleiberg H, Kemeny N, Rougier P, Wilke HJ, eds. Colorectal Cancer. A Clinical Guide to Therapy. London: Martin Dunitz, 2002: 673-82.
90. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-44.
91. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993.
92. Michelson H, Bolund C, Nilsson B, Brandberg Y. Health related quality of life measured by the EORTC QLQ-C30: Reference values from a large sample of the Swedish population. Acta Oncol 2000; 39: 477-85.
93. Hays RD, MWJ. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 2000; 18: 419-23.
94. Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, Symonds T. Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 2002; 77: 367-70.